Differential expression of N-cadherin in pleural mesotheliomas and E- cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues

Human Pathology

Volumn 28, Issue 6, 1997, Pages 641-645

  Han, Aaron C ^b   Peralta Soler, Alejandro ^b   Knudsen, Karen A ^b   Wheelock, Margaret J ^b   Johnson, Keith R ^b   Salazar, Hernando ^a  

^a READING HOSPITAL AND MEDICAL CENTER   (United States)

^b NONE

Author keywords

Cadherins; Lung adenocarcinoma; Paraffin immunohistochemistry; Pleural mesothelioma

Indexed keywords

MONOCLONAL ANTIBODY; NERVE CELL ADHESION MOLECULE; UVOMORULIN;

ANTIGEN EXPRESSION; ARTICLE; DIFFERENTIAL DIAGNOSIS; HEMANGIOPERICYTOMA; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; PLEURA EFFUSION; PLEURA MESOTHELIOMA; TISSUE FIXATION;

EID: 0030910864     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90171-4     Document Type: Article

References (37)

1. Weiss LW, Battifora H: The search for the optimal immunohistochemical panel for the diagnosis of malignant mesothelioma. HUM PATHOL 24:345-346, 1993
2. Shelbani K: Immunopathology of malignant mesothelioma. HUM PATHOL 25:219-220, 1994
3. Sheibani K, Esteban JM, Bailey A, et al: Immunopathological and molecular studies as an aid to the diagnosis of malignant mesothelioma. HUM PATHOL 23:107-116, 1993
4. Brown RM, Clark GM, Tandon AK, et al: Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. HUM PATHOL 24:347-354, 1993
5. Wick MR, Mills SE, Swanson PE: Expression of "myelomonocytic" antigens in mesotheliomas and adenocarcinomas involving the serosal surfaces. Am J Clin Pathol 94:18-26, 1990
6. Gaffey MJ, Mills SE, Swanson PE, et al: Immunoreactivity for BER-EP4 in adenocarcinomas, adenomatoid tumors, and malignant mesotheliomas. Am J Surg Pathol 16:593-599, 1992
7. y in the diagnostic discrimination of malignant mesothelioma versus adenocarcinoma. Am J Pathol 135:931-937, 1989
8. Warhol MJ, Hickey MF. Corson JM: Malignant mesotheliomas: Ultrastructural distinction from adenocarcinoma. Am J Surg Pathol 6:307-314, 1982
9. Geiger B, Ayalon O: Cadherins. Annu Rev Cell Biol 8:307-332, 1992
10. Wheelock MJ, Knudsen KA: Cadherins and associated proteins. In Vivo 5:505-514, 1991
11. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulators. Science 251:1451-1455, 1991
12. 2+-dependent adhesion molecule, N-cadherin, in myoblast interaction during myogenesis. Exp Cell Res 188:175-184, 1990
13. Peralta Soler A, Knudsen KA: N-cadherin involvement in cardiac myocyte interaction and myofibrillogenesis. Develop Biol 16:9-17, 1994
14. Peralta Soler A, Knudsen KA, Jaurand MC, et al: The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas. HUM PATHOL 26:1363-1369, 1995
15. Knudsen KA, Peralta Soler A, Johnson KR, et al: Interaction of a-actinin with the cadherin/catenin cell-cell adhesion complex via a-catenin. J Cell Biol 130:67-77, 1995
16. Wheelock MJ, Buck CA, Bechtol KB, et al: The soluble GP80 fragment of cell CAM 120/80 disrupts cell-cell adhesion. J Cell Biochem 34:187-202, 1987
17. Shi SR, Gu J, Kalra KL, et al: Antigen retrieval technique: A novel approach to immunohistochemistry on routinely processed tissue sections. Cell Vision 2:6-22, 1995
18. Miettinen M, Kovatich AJ: HBME-1 A monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma, and soft-tissue and bone tumors. Appl Immunohistochem 3:115-122, 1995
19. O'Hara CJ, CorsonJM, Pinkus GS, et al: ME1, a monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies. Am J Pathol 136:421-428, 1990
20. Amin KM, Litzky LA, Smythe WR, et al: Wilms' tumor susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. AmJ Pathol 146:344-356, 1995
21. Chang K, Pal LH, Pass H, et al: Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma. Am J Surg Pathol 16:259-268, 1992
22. Doglioni C, DeiTos AP, Laurino L, et al: Calretinin: A novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 20:1037-1046, 1996
23. Gamallo C, Palacios J, Suarez A, et al: Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142:987-993, 1993
24. Matsuura K, Kawanishi J, Fujii S, et al: Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid. Br J Cancer 66:1122-1130, 1992
25. Mayer B, Johnson JP, Leitl F, et al: E-cadherin expression in primary and metastatic gastric cancer: Down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 53:1690-1695, 1993
26. Yonemura Y, Nojima N, Kaji M, et al: E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma. Cancer 76:941-953, 1995
27. Shino Y, Watanabe A, Yamada Y, et al: Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas. Cancer 76:2193-2201, 1995
28. Kinsella AR, Green B, Lepts GC, et al: The role of the cell-cell adhersion molecule E-cadherin in large bowel tumor cell invasion and metastasis. Br J Cancer 67:904-909, 1993
29. Hashimoto M, Niwa O, Nitta Y, et al: Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn J Cancer Res 80:459-463, 1989
30. Ross JS, DelRosario AD, Figge HL, et al: E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder. HUM PATHOL 26:940-944, 1995
31. Ross JS, Figge HL, Bui HX, et al: E-cadherin expression in prostatic carcinoma biopsies: Correlation with tumor grade, DNA content, pathologic stage and clinical outcome. Mod Pathol 7:835-841, 1994
32. Schipper JH, Frixen UH, Behrens J, et al: E-cadherin expression in squamous cell carcinoma of head and neck: Inverse correlation with differentiation and lymph node metastasis. Cancer Res 51:6328-6337, 1991
33. Vessey CJ, Wilding J, Folarin N, et al: Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol 176:151-159, 1995
34. Frixen U, Behrens J, Sachs M, et al: E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cell lines. J Cell Biol 117:173-185, 1991
35. Shiozaki H, Oka H. Inoue M, et al: E-cadherin mediated adhesion system in cancer cells. Cancer 77:1605-1613, 1996
36. Takeichi M: Cadherins in cancer: Implications for invasion and metastasis. Curr Opin Cell Biol 5:806-811, 1993
37. Hedrick L, Cho KR, Vogelstein B: Cell adhesion molecules as tumour suppressors. Trends Cell Biol 3:36-39, 1993